How binding site water and inhibitor protonation modulate the selectivities of beta-secretase 1 inhibitors

被引：0
|
作者：
Shen, Jana [1 ]
Henderson, Jack [1 ]
机构：
[1] Univ Maryland, Sch Med, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
580
引用
收藏
页数：1
相关论文
共 28 条
  • [21] RELATIVE BINDING FREE-ENERGIES OF PEPTIDE INHIBITORS OF HIV-1 PROTEASE - THE INFLUENCE OF THE ACTIVE-SITE PROTONATION STATE
    CHEN, XN
    TROPSHA, A
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (01) : 42 - 48
  • [22] Novel γ-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1
    Wu, Fang
    Schweizer, Claude
    Rudinskiy, Nikita
    Taylor, David M.
    Kazantsev, Aleksey
    Luthi-Carter, Ruth
    Fraering, Patrick C.
    FASEB JOURNAL, 2010, 24 (07): : 2464 - 2474
  • [23] Alpha-hydroxytropolones are noncompetitive inhibitors of human RNase H1 that bind to the active site and modulate substrate binding
    Ponzar, Nathan L.
    Tajwar, Razia
    Pozzi, Nicola
    Tavis, John E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (04)
  • [24] Modeling Binding of Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitor Aminoquinoline (68 K) for Possible Treatment of Alzheimer's Disease
    Dalal, Juhi
    Averineni, Shreya
    Madadi, Pranav
    Lavin, Emily Schmitt
    Sikora, Arthur
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S552 - S552
  • [25] Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors
    Radi, Marco
    Falchi, Federico
    Garbelli, Anna
    Samuele, Alberta
    Bernardo, Vincenzo
    Paolucci, Stefania
    Baldanti, Fausto
    Schenone, Silvia
    Manetti, Fabrizio
    Maga, Giovanni
    Botta, Maurizio
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (05) : 2094 - 2098
  • [26] RAPID INDUCTION IN REGENERATING LIVER OF RL/IF-1, AN IKB-BETA-LIKE INHIBITOR OF NF-KB, RELB AND C-REL - AND PHF-1, A NOVEL KB SITE BINDING-FACTOR
    TEWARI, M
    MOHN, KL
    HSU, JC
    TAUB, R
    CLINICAL RESEARCH, 1992, 40 (02): : A312 - A312
  • [27] ANALYSES OF CATALYTIC ACTIVITY AND INHIBITOR BINDING OF HUMAN ACID BETA-GLUCOSIDASE BY SITE-DIRECTED MUTAGENESIS - IDENTIFICATION OF RESIDUES CRITICAL TO CATALYSIS AND EVIDENCE FOR CAUSALITY OF 2 ASHKENAZI JEWISH GAUCHER DISEASE TYPE-1 MUTATIONS
    GRACE, ME
    GRAVES, PN
    SMITH, FI
    GRABOWSKI, GA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (12) : 6827 - 6835
  • [28] ASPARTYL ALPHA-((1-PHENYL-3-(TRIFLUOROMETHYL)PYRAZOL-5-YL)OXY)METHYL KETONES AS INTERLEUKIN-1-BETA CONVERTING-ENZYME INHIBITORS - SIGNIFICANCE OF THE P-1 AND P-3 AMIDO NITROGENS FOR ENZYME-PEPTIDE INHIBITOR BINDING
    DOLLE, RE
    SINGH, J
    RINKER, J
    HOYER, D
    PRASAD, CVC
    GRAYBILL, TL
    SALVINO, JM
    HELASZEK, CT
    MILLER, RE
    ATOR, MA
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) : 3863 - 3866
123